Image

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Exploring new treatment options for resistant multiple myeloma in adults.

Recruiting
18 years and older
All
Phase 1

This study is testing a new experimental drug called linvoseltamab for adults with multiple myeloma, a type of blood cancer. Multiple myeloma is when cancer cells grow in the bone marrow, which can make people very sick. Linvoseltamab has already shown promise when used alone in past studies, but this is the first time it's being tested with other treatments to see if they work better together.

The main goal is to find out if linvoseltamab is safe to use with other cancer drugs and to determine the right dose. Researchers also want to see how well the drug works, if it causes any side effects, and how it acts in the body.

  • The study involves taking the drug with other treatments, which may have side effects.
  • Participants need to have previously tried other cancer treatments.
  • Doctors will closely monitor patients' health throughout the study.
Study details
    Multiple Myeloma

NCT05137054

Regeneron Pharmaceuticals

22 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.